Bauchi State Governor, Bala Mohammed, has done the unprecedented.
Without any clearance from the Ministry of Health, NCDC or NAFDAC, he has given an approval for the use of Chloroquine and Zithromax, in his state, for the cure of the deadly Coronavirus.
During a Press Conference in Bauchi, on Thursday, he ordered, and authorized health officials to go for Chloroquine and Zithromax, saying he should be held responsible for the outcome.
Surprisingly, neither Federal Government, the Ministry of Health, NCDC, nor NAFDAC, has taken him up on that.
The Governor was an early victim of Coronavirus in Nigeria.
The Governor’s prescription is welm beyond his area of competence and authority. But, he boldly said he is ready to take responsibility for any consequence of approving such drugs, because they worked for him and some victims in his State.
Bala, who was the COVID-19 index case in the state, revealed that he was treated with chloroquine and Zithromax.
“Our medical team is using their own ingenuity to use chloroquine and Zithromax to treat the patients, even though in some places, they said it is against the protocol,” he said.
“As the governor, I’m taking responsibility for that because I don’t want anyone to die.
“I have given you the directive that you must use something that I have used to get well, just as you have used for all other cases that got well.
“Rather than saying that something is harmful, we should not follow what the white people are saying by not taking anything and die.
“We are used to taking chloroquine in Nigeria. We are going to use them. We have taken responsibility and I have taken responsibility.
“Zithromax and chloroquine are not harmful to our body, our physiological system has adapted to it. If you are having a fever you take chloroquine,” he said.
Recall that the US President, Donald Trump, had also recommended the use of Chloroquine in the US, but the idea was quickly shot down by professionals who have been, frantically, working to develop a Vaccine for the Virus.
Discover more from The Source
Subscribe to get the latest posts sent to your email.